Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

104.77 -0.47 (-0.45%)
Official Closing Price Updated: 4:10 PM EDT, Jul 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,450,473
Open 100.59
Bid (Size) 104.40 (1)
Ask (Size) 104.50 (1)
Prev. Close 105.24
Today's Range 99.92 - 105.17
52wk Range 89.67 - 121.64
Shares Outstanding 1,750,942,289
Dividend Yield 1.95%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Healthcare Stocks Are Coming On Strong In July Led By Biotech
The biotech rally gained momentum in July with rotation out of technology stocks. 
Via Talk Markets
Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today?
NLS Pharmaceutics stock is up on Monday after the company provided NLSP investors with details on a merger deal with Kadimastem. 
Via InvestorPlace

Performance

YTD
-4.62%
-4.62%
1 Month
+0.83%
+0.83%
3 Month
-2.33%
-2.33%
6 Month
-7.65%
-7.65%
1 Year
-5.89%
-5.89%

More News

Read More
Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today?
Via InvestorPlace
Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.
Via InvestorPlace
3 High-Yield Dividend Stocks That Are Looking Super Hot
Via InvestorPlace
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Abbott Laboratories's Options Frenzy: What You Need to Know
Via Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
Via Benzinga
US Stocks Look To Extend Gains Ahead Of Key Tech Earnings, FOMC Meeting: Analyst Says This 'Could Serve As A Fundamental Catalyst For Small And Mid-Cap'
Via Benzinga
Abbott Laboratories Tumble Nearly 8% In Pre-Market After US Jury Charges $495M Penalty For Disease Causing Baby Formula
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Is Beaten-Down Dexcom Stock a Buy on the Dip?
Via The Motley Fool
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Behind the Scenes of Abbott Laboratories's Latest Options Trends
Via Benzinga
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?
Via InvestorPlace
Better Buy: Abbott Laboratories vs. Intuitive Surgical
Via The Motley Fool
3 High-Yielding Dividend Stocks That Can Help Bankroll Your Retirement Years
Via The Motley Fool
Topics Retirement
Exposures Pension
7 Trustworthy Dividend Stocks to Steadily Build Your Portfolio
Via InvestorPlace
Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
Via The Motley Fool
10 Best Dividend Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
Via Investor's Business Daily
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Via Benzinga
Dow Plunges Over 500 Points Following Unexpected Surge In US Jobless Claims
Via Benzinga
Topics Stocks
Exposures US Equities
7 Safe Stocks to Buy for Volatility Insurance
Via InvestorPlace
Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.